Viant to Manufacture Venclose's RF Ablation Catheter for Venous Reflux Disease

 

January 30, 2019—Venclose Inc. and Viant announced a partnership for the manufacture of Venclose’s next-generation Venclose radiofrequency (RF) ablation catheter. The Venclose RF system is designed to close the damaged vein and restore healthy blood flow in patients with venous reflux disease. The Venclose RF system is available in the United States and Europe.

Venclose, based in San Jose, California, is a developer of treatments for chronic venous insufficiency. Viant is an ISO-certified medical device contract manufacturer with headquarters in Foxborough, Massachusetts. The Venclose system will be transferred to Viant’s manufacturing facility in Costa Rica in Q3 2019 to allow for market expansion.

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.